Fund shareholders of Agios Pharmaceuticals Inc
ISIN US00847X1046 · United States · LEI 529900ONJHY8EOGYT555
- Fund shareholders
- 227
- Of which ETFs
- 48 179 other funds
- Value held
- 616.2M $ 6.2M SEK
- Share of capital
- 32.2 % of 59.7M shares on Jul 24, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Small Company Value Portfolio Wilshire Mutual Funds Inc | 630 | 21.3K $ | 0.09 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT AGGRESSIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 623 | 21.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 615 | 18.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| THRIVENT MODERATE ALLOCATION FUND Thrivent Mutual Funds | 475 | 13.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| THRIVENT GLOBAL STOCK FUND Thrivent Mutual Funds | 427 | 12K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 403 | 13.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT GLOBAL STOCK PORTFOLIO Thrivent Series Fund, Inc. | 353 | 11.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 340 | 11.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 310 | 8.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 300 | 10.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 280 | 9.5K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 264 | 7.4K $ | 0.10 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Small-Cap Equity V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 249 | 8.4K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Moderate Allocation Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 227 | 7.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 200 | 6.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 189 | 6.4K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 143 | 4.8K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 127 | 4.3K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 114 | 3.2K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 103 | 2.9K $ | 0.04 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 77 | 2.6K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION FUND Thrivent Mutual Funds | 68 | 1.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 58 | 1.8K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 55 | 1.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 54 | 1.8K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 18 | 544.1 $ | 0.05 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 15 | 507.5 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Virtus Biotech Etf ETFis Series Trust I | 1.64 % | as of Apr 30, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 1.57 % | as of Mar 31, 2026 ↗ |
| AMG GW&K Small Cap Value Fund AMG Funds | 1.23 % | as of Mar 31, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 1.20 % | as of Mar 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 1.14 % | as of Feb 28, 2026 ↗ |
| AMG GW&K Small/Mid Cap Growth Fund AMG Funds IV | 1.02 % | as of Apr 30, 2026 ↗ |
| AMG GW&K Small Cap Core Fund AMG Funds | 1.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.88 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.86 % | as of Mar 31, 2026 ↗ |
| Kennedy Capital ESG SMID Cap Fund INVESTMENT MANAGERS SERIES TRUST II | 0.81 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 226 | +18 | 19,184,618 | +8.9 % |
| 2026Q1 | 208 | -19 | 17,618,879 | -4.8 % |
| 2025Q4 | 227 | -3 | 18,516,222 | -1.0 % |
| 2025Q3 | 230 | -3 | 18,694,632 | -1.2 % |
| 2025Q2 | 233 | +6 | 18,930,858 | -0.9 % |
| 2025Q1 | 227 | +5 | 19,100,997 | -6.0 % |
| 2024Q4 | 222 | -3 | 20,321,395 | -1.5 % |
| 2024Q3 | 225 | -2 | 20,627,277 | -8.7 % |
| 2024Q2 | 227 | +10 | 22,583,992 | +1.7 % |
| 2024Q1 | 217 | -7 | 22,213,116 | -10.1 % |
| 2023Q4 | 224 | 24,713,098 |
Institutional managers
224 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 5,754,957 | 194.7M $ | as of Mar 31, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | 5,684,000 | 192.3M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 3,364,879 | 113.7M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 2,716,000 | 91.9M $ | as of Mar 31, 2026 |
| Erste Asset Management GmbH | 2,704,900 | 80.1M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 2,681,169 | 90.7M $ | as of Mar 31, 2026 |
| Lynx1 Capital Management LP | 2,611,568 | 88.3M $ | as of Mar 31, 2026 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1,580,840 | 53.5M $ | as of Mar 31, 2026 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 1,494,435 | 50.6M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 1,488,740 | 50.4K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,467,910 | 49.7M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,344,953 | 45.5M $ | as of Mar 31, 2026 |
| MPM BIOIMPACT LLC | 1,306,261 | 44.2M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 1,256,080 | 42.5M $ | as of Mar 31, 2026 |
| GW&K Investment Management, LLC | 1,214,901 | 41.1K $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,151,614 | 38.9M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 967,525 | 32.7M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 805,776 | 27.3M $ | as of Mar 31, 2026 |
| Rock Springs Capital Management LP | 799,163 | 27M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 722,348 | 24.4M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 685,240 | 23.2M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 641,486 | 21.7M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 619,613 | 21M $ | as of Mar 31, 2026 |
| SCS Capital Management LLC | 612,850 | 20.7M $ | as of Mar 31, 2026 |
| Foresite Capital Management VI LLC | 525,000 | 17.8M $ | as of Mar 31, 2026 |
Declared shareholders of Agios Pharmaceuticals Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 5.27 % | 3,088,169 | as of Mar 31, 2026 · SCHEDULE 13G |
| Lynx1 Capital Management LP and 1 other | 5.10 % | 3,013,949 | as of Apr 29, 2026 · SCHEDULE 13G |
| Armistice Capital, LLC and 1 other | 4.57 % | 2,716,000 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Agios Pharmaceuticals Inc". https://titelia.com/en/stocks/agios-pharmaceuticals-inc-US00847X1046